Form 8-K ANTARES PHARMA, INC. For: Aug 07
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140807/AF2VL22EZZ2RV2ZZ2RZ82WXRI3GKZZ22Z26Q
Filed on: August 7, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ripple’s XRP Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement
- As the Lights Fade, Vivid Sydney 2026 Leaves the City Glowing
- Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
